代谢手术长期缓解2型糖尿病
Weight-loss surgery produces lasting diabetes remission, long-term study finds
一项长期研究发现,接受代谢手术的2型糖尿病患者糖尿病缓解率远高于仅接受药物和生活方式管理的患者。研究还识别了预测长期缓解的因素。
研究揭示了代谢手术在糖尿病长期缓解中的效果,并识别了预测因素,有助于更精准地选择手术对象。
People with type 2 diabetes were much more likely to achieve remission after weight-loss surgery than after intensive medical and lifestyle management, according to a long-term study. Researchers also identified patient characteristics linked to remission and to the likelihood of diabetes returning.
The study, published in Diabetes Care, found that 58% of participants assigned to metabolic-bariatric surgery achieved diabetes remission, compared with 3% of those assigned to medical and lifestyle management. Participants were followed for a median of 11 years, with some followed for up to 14 years.
Researchers found that people who had lived with diabetes for fewer years, did not use insulin and took fewer types of blood sugar-lowering medications before treatment were more likely to achieve remission. Greater weight loss during the first year after treatment was also associated with a higher likelihood of remission.
The Alliance of Randomized Trials of Medicine vs. Metabolic Surgery in Type 2 Diabetes (ARMMS-T2D) is the largest, longest-running trial of metabolic surgery for diabetes. The study's lead author is Donald Simonson, M.D., MPH, Sc.D., of Brigham and Women's Hospital and Harvard Medical School in Boston. The principal investigator is John P. Kirwan, Ph.D., who this summer was named executive director of the University of Oklahoma Health Harold Hamm Diabetes Center. Kirwan also serves as vice provost for diabetes programs at the University of Oklahoma and holds the Chickasaw Nation Endowed Chair in Diabetes Research.
"For years, one of the most consequential questions in diabetes care has been whether the benefits of metabolic surgery endure," Kirwan said. "Now we have a durable answer. Over 14 years, 58% of surgical patients achieved remission, compared with just 3% on medication and lifestyle alone. By identifying who is most likely to achieve lasting remission, including shorter diabetes duration, no insulin use and greater early weight loss, we can offer surgery to the right people earlier, rather than as a last resort."
The analysis also identified factors associated with diabetes returning after an initial remission. People who had lived with diabetes longer and those taking more types of blood sugar-lowering medications before treatment were more likely to relapse. The findings suggest that a patient's history of diabetes and response to treatment may help physicians assess the likelihood of remission and its potential duration.
Researchers analyzed data from 262 people with type 2 diabetes. Of those participants, 166 were assigned to metabolic-bariatric surgery and 96 to medical and lifestyle management. The study defined remission as an A1C below 6.5% without medication to lower blood sugar. A1C is a blood test that measures average blood sugar levels over approximately three months.
Publication details
Donald C. Simonson et al., Predictors of Type 2 Diabetes Remission and Relapse After Metabolic-Bariatric Surgery or Medical-Lifestyle Therapy in the ARMMS-T2D Study, Diabetes Care (2026). DOI: 10.2337/dc26-1070
Journal information: Diabetes Care
Key medical concepts
Who's behind this story?
Lisa Lock
BA art history, MA material culture. Former museum editor, paramedic, and transplant coordinator. Editing for Science X since 2021. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Weight-loss surgery produces lasting diabetes remission, long-term study finds (2026, October 26) retrieved 26 October 2026 from https://medicalxpress.com/news/2026-10-weight-loss-surgery-diabetes-remission.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com